Technical Analysis for FLXN - Flexion Therapeutics, Inc.

Grade Last Price % Change Price Change
grade C 10.99 2.42% 0.26
FLXN closed up 2.42 percent on Friday, August 16, 2019, on 79 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions. The stock rose above its 50 day moving average, improving its intermediate-term outlook by crossing above that important trendline.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Down Up Up
See historical FLXN trend table...

Date Alert Name Type % Chg
Crossed Above 50 DMA Bullish 0.00%
NR7 Range Contraction 0.00%
NR7-2 Range Contraction 0.00%
Fell Below 50 DMA Bearish 2.42%
Calm After Storm Range Contraction 2.42%
NR7 Range Contraction 2.42%
Overbought Stochastic Strength 2.42%
Stochastic Sell Signal Bearish 0.55%
50 DMA Support Bullish 0.55%
Overbought Stochastic Strength 0.55%

Older signals for FLXN ...

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
Profile
Flexion Therapeutics, Inc. focuses on the development and commercialization of anti-inflammatory and analgesic therapies for the treatment of patients with musculoskeletal conditions. Its lead product candidate includes FX006, an intra-articular, sustained-release triamcinolone acetonide, which has completed a Phase 2b dose-ranging clinical trial to treat moderate to severe osteoarthritis (OA) pain. The company is also developing FX007, a preclinical, small-molecule TrkA receptor antagonist to address post-operative pain; and FX005, an intra-articular, sustained-release p38 MAP kinase inhibitor, which has completed a Phase 2a clinical trial to treat end-stage OA patients. Flexion Therapeutics, Inc. was founded in 2007 and is headquartered in Burlington, Massachusetts.
Chemistry Pain Organic Compounds Organic Chemistry Osteoarthritis Arthritis Glucocorticoids Skeletal Disorders Organofluorides Tropomyosin Receptor Kinase A
Is FLXN a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 1 bullish, 1 bearish and 3 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 23.1
52 Week Low 8.76
Average Volume 577,858
200-Day Moving Average 12.5857
50-Day Moving Average 10.8826
20-Day Moving Average 10.2405
10-Day Moving Average 10.612
Average True Range 0.6992
ADX 18.97
+DI 23.616
-DI 20.3781
Chandelier Exit (Long, 3 ATRs ) 9.8424
Chandelier Exit (Short, 3 ATRs ) 10.8576
Upper Bollinger Band 11.7661
Lower Bollinger Band 8.7149
Percent B (%b) 0.75
BandWidth 29.79542
MACD Line 0.0727
MACD Signal Line -0.1085
MACD Histogram 0.1812
Fundamentals Value
Market Cap 350.64 Million
Num Shares 31.9 Million
EPS -3.11
Price-to-Earnings (P/E) Ratio -3.53
Price-to-Sales 0.00
Price-to-Book 3.08
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 11.52
Resistance 3 (R3) 11.50 11.30 11.43
Resistance 2 (R2) 11.30 11.17 11.31 11.40
Resistance 1 (R1) 11.15 11.09 11.23 11.17 11.37
Pivot Point 10.95 10.95 10.99 10.96 10.95
Support 1 (S1) 10.80 10.82 10.88 10.82 10.61
Support 2 (S2) 10.60 10.74 10.61 10.58
Support 3 (S3) 10.45 10.60 10.55
Support 4 (S4) 10.47